HomeKRBPQ • OTCMKTS
add
Kiromic Biopharma Inc
Previous close
$0.00010
Market cap
150.00 USD
Avg Volume
318.00
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.70M | — |
Net income | -6.49M | — |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -5.14M | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.14M | — |
Total assets | 8.54M | — |
Total liabilities | 21.13M | — |
Total equity | -12.59M | — |
Shares outstanding | 1.53M | — |
Price to book | -0.00 | — |
Return on assets | -151.81% | — |
Return on capital | -385.11% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -6.49M | — |
Cash from operations | -3.65M | — |
Cash from investing | -28.00K | — |
Cash from financing | 2.42M | — |
Net change in cash | -1.26M | — |
Free cash flow | -2.35M | — |
About
Founded
2006
Headquarters
Website
Employees
44
